NCT06741345View on ClinicalTrials.gov

Phase 1 BIO 300 Oral Suspension

PHASE1RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 23, 2024

Primary Completion Date

August 15, 2025

Study Completion Date

August 15, 2025

Conditions
Healthy Volunteer Study
Interventions
DRUG

BIO 300 Oral Suspension

Suspension of genistein nanoparticles for oral administration

Trial Locations (1)

55114

RECRUITING

Nucleus Network, LLC, Saint Paul

Sponsors
All Listed Sponsors
lead

Humanetics Corporation

INDUSTRY

NCT06741345 - Phase 1 BIO 300 Oral Suspension | Biotech Hunter | Biotech Hunter